Quamed

24/01/2026

In Damascus this week with colleagues from the European Union and the وزارة الصحة السورية, visiting the national quality control laboratory.

This EU-funded mission is part of a broader effort to support the Syrian pharmaceutical sector, strengthen local capacities, and ultimately improve access to safe, effective, and quality medicines.

A valuable moment of collaboration, learning, and shared commitment to public health.

Thanks to COAR Global and Hera

20/01/2026

The following message is courtesy of Dr Raffaella Ravinetto, Public Health Department, Institute of Tropical Medicine Antwerp, Belgium.

Ref M Lambert, S Aljadeeah, N Nasir, F Sila, L Lopes, C Llor. Reducing antibiotic exposure to combat antimicrobial resistance: rethinking use, packaging, and dispensing practices. The Lancet Primary Care, 2025, 100084, https://www.thelancet.com/journals/lanprc/article/PIIS3050-5143(25)00084-6/fulltext

Dear Friends,

Today I would like to share an open access Viewpoint authored, among others, by my colleague Saleh Aljadeeah in The Lancet Primary Care.

After framing the global health threat represented by AMR in the broader context of structural inequities, weak regulatory systems, and low access to care in LMICs, the authors discuss the possible strategies to reduce unnecessary antibiotic exposure.

These include, but are not limited to, optimizing antibiotic treatment via evidence-based shorter antibiotic courses; addressing barriers to treatment adherence, via patient-centred approaches; correcting context-related determinants of poor adherence, such as poor diagnostic infrastructure, limited access/affordability, and weak supply chain etc.; reducing unregulated use of leftovers, by reforming antibiotics packaging and adopting exact-dose dispensing; reducing antibiotics use without prescription and combating substandard and falsified antibiotics. The latter requires addressing the underlying causes, by strengthening regulation and healthcare access, expanding universal health coverage, and making rapid diagnostic tests affordable.

Reading the full text clearly shows that efficiently combating and preventing AMR to preserve antibiotic effectiveness for future generations. requires integrated strategies that address systemic barriers, including the social determinants of poor use.

Have a nice reading,

Raffaella

20/01/2026

What happens when a medical product can’t be traced back to its source? Patient safety is put at risk. Join the Peer Learning Certificate on Traceability in Health Supply Chains, a free, four-week, discussion-led program designed for professionals working across health product supply chains. Through short learning summaries, real-world case studies, and guided peer discussions, you’ll explore why traceability matters, how stakeholders respond, and how digital tools help prevent substandard and falsified medicines. Learn alongside peers from Africa and beyond, and earn a free certificate upon completion.

Program shared by Sanjay Saha
Register today:

Learning & Networking

15/01/2026

Quamed supported the delivery of an in-country Good Storage and Distribution Practices (GSDP) workshop in partnership with SEARN (South-East Asia Regulatory Network) and WHO, which built on prerequisite online courses (https://learning.quamed.org/) and regional virtual sessions.

The workshop aimed to strengthen the practical capacity of mid-level and junior inspectors to plan, conduct, and report regulatory inspections in line with WHO GSDP guidance. This included training, coached inspections, and inspection report reviews. Through a hands-on approach, our experts, Solomon Onen and MUHAMMAD LUKWAGO, enabled participants to apply practical inspection skills and risk-based methodologies.

Coached inspections were conducted with the support of our experts at wholesaler sites identified by the host NRAs. Up to ten participants from the Maldives (Maldives Food and Drug Authority MFDA) and Bangladesh NRAs (Directorate General of Drug Administration (DGDA)) attended these coached inspections to maximise learning impact.

This is a strong example of how practical, risk-based capacity building can strengthen regulatory oversight and improve supply chain quality.

14/01/2026

QUAMED is looking for a short-term consultant to support the completion of an internal human resources audit.
The consultant will be primarily responsible for evaluating HR strategy, managing employment contracts and personnel administration, overseeing payroll processes, and developing compensation frameworks.

The ideal candidate will have solid experience in human resources management within complex international organisations, as well as excellent knowledge of Belgian and French social legislation. Previous experience as an auditor or evaluator would be an asset. organisations

For more information, take a look here:

Terms of Reference for a consultant providing support for human resources internal audit About QUAMED QUAMED is a not-for-profit association with a mission to improve access to quality medicines for all. QUAMED is a global membership organization that brings together international Non-Governmental

12/01/2026

At Quamed, we believe that access to quality medicines begins with trust, collaboration, and especially with sharing knowledge and information. The Quamed Database is more than a tool, it’s a collective space where professionals come together to consult reliable information on suppliers’ pharmaceutical practices. Built from insights gathered during Quamed audits, it brings reliable information on manufacturers and distributors into one secure place. By joining the Database, you become part of a community working hand in hand to make quality medicines more accessible, everywhere.

Have a look here at which reports you could access: https://database.quamed.org/

For more information on how to subscribe and join, please contact us.

07/01/2026

In December, QUAMED launched a technical support initiative for five French NGOs that are members of QUAMED.

This support aims to assist these organisations in their application to open a humanitarian pharmaceutical distribution establishment, authorised by the French National Agency for the Safety of Medicines and Health Products (ANSM).

The project focuses on:

- The development and strengthening of quality management systems,
- The preparation of regulatory dossiers for submission to the ANSM,
- As well as the external evaluation of these dossiers.

The project was officially launched through a two-day workshop held in Paris on 16–17 December 2025, bringing together the reference pharmacists from the participating NGOs. The workshop enabled the collective definition of the scope, governance, and implementation timeline of the project.

Anthony Bourasseau is acting as the expert mandated by QUAMED for the implementation of this initiative.

06/01/2026

The following message is courtesy of Dr Raffaella Ravinetto, Public Health Department, Institute of Tropical Medicine Antwerp, Belgium.

Register here: https://vive.nemtilmeld.dk/170/

01/01/2026

Happy New Year 2026! 🎉

Cheers to a new year of bold ideas, strong partnerships, and shared impact! Quamed wishes all our followers, partners, members, and friends a joyful, healthy, and inspiring 2026. Thank you for being part of our growing community. Let’s make this year even brighter together!

25/12/2025

🎄 Merry Christmas from Quamed 🎄

As we celebrate this festive season, we extend our heartfelt thanks to our partners and colleagues around the world. Your trust, collaboration, and shared commitment to quality healthcare make our work meaningful every day.

May this Christmas bring you peace, joy, and time to reflect on all we’ve achieved together. We look forward to continuing our collaboration and making an even greater impact in the year ahead.

✨ Merry Christmas and warm wishes from all of us at Quamed. ✨

18/12/2025

We’re delighted to share some great news 🎉🎉

QUAMED has officially issued a QCP GSDP certificate to Ltd. This certification recognises their compliance with the World Health Organisation’s Good Storage and Distribution Practices, reinforcing their commitment to quality, safety, and reliability across the supply chain.

We warmly congratulate Phillips Pharmaceuticals Ltd. (Zambia) and their dedicated team for reaching this important milestone. Their achievement reflects strong systems, responsible practices, and a shared mission to ensure access to quality-assured medical products.

You can find the certificate and more details on the QUAMED QCP: https://quamed.org/quality-certification-program/

17/12/2025

Strengthening Pharmaceutical Inspectors’ Skills in Benin

As part of the REG-PHARMA project, funded by the French Development Agency (AFD) and implemented by Expertise France, Quamed is supporting ABMed, the Pharmaceutical Regulatory Authority of Benin, to strengthen its inspectors’ skills in regulatory inspections, with a focus on pharmaceutical establishments (distributors and manufacturers).

Since July 2025, ABMed inspectors have participated in several GSDP and GMP audits conducted by Quamed.

- In November, 8 junior GSDP inspectors were trained through coached inspections with our auditors Laurine Lavergne and Jean-Christophe Pélissier.
- In January, 6 junior GMP inspectors will deepen their knowledge and apply it during coached inspections in Tunisia.


These activities enable inspectors to:

- Identify critical areas and risk points
- Apply risk-based inspection techniques
- Plan and conduct inspections using Quality Risk Management principles
- Prepare and categorise inspection observations and findings

They also help develop key skills: observation, questioning, triangulation, validation, critical thinking, communication, and decision-making.

Thank you to ABMed for their collaboration and to our auditors for their expert support!